 Valerie Minarchick
Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 6 | 2019 | 341 | 1.260 |
Why?
| | Cerium | 2 | 2014 | 25 | 1.100 |
Why?
| | Vasodilation | 3 | 2014 | 476 | 0.890 |
Why?
| | Arterioles | 3 | 2014 | 48 | 0.740 |
Why?
| | Coronary Vessels | 3 | 2015 | 283 | 0.590 |
Why?
| | Mesentery | 1 | 2014 | 79 | 0.560 |
Why?
| | Mesenteric Arteries | 1 | 2013 | 15 | 0.540 |
Why?
| | Titanium | 4 | 2019 | 68 | 0.500 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2014 | 247 | 0.490 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2014 | 482 | 0.480 |
Why?
| | Particulate Matter | 3 | 2015 | 202 | 0.350 |
Why?
| | Lung | 3 | 2019 | 3637 | 0.300 |
Why?
| | Rats, Sprague-Dawley | 7 | 2015 | 3027 | 0.280 |
Why?
| | Reactive Oxygen Species | 5 | 2019 | 560 | 0.270 |
Why?
| | Microcirculation | 3 | 2013 | 165 | 0.260 |
Why?
| | Signal Transduction | 2 | 2019 | 4923 | 0.230 |
Why?
| | Extracellular Traps | 1 | 2021 | 37 | 0.230 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2021 | 78 | 0.220 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2014 | 2229 | 0.210 |
Why?
| | Granulocyte Precursor Cells | 1 | 2019 | 9 | 0.210 |
Why?
| | Zinc Oxide | 1 | 2019 | 12 | 0.200 |
Why?
| | Silver | 1 | 2019 | 26 | 0.200 |
Why?
| | Environmental Exposure | 3 | 2019 | 424 | 0.200 |
Why?
| | Sputum | 1 | 2021 | 286 | 0.200 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2019 | 96 | 0.190 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 78 | 0.190 |
Why?
| | Toxicity Tests | 2 | 2019 | 29 | 0.180 |
Why?
| | Particle Size | 2 | 2019 | 409 | 0.170 |
Why?
| | Administration, Inhalation | 2 | 2014 | 649 | 0.150 |
Why?
| | Air Pollutants, Occupational | 1 | 2015 | 39 | 0.150 |
Why?
| | Chromium | 1 | 2015 | 12 | 0.150 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2014 | 16 | 0.150 |
Why?
| | Cadmium | 1 | 2015 | 53 | 0.150 |
Why?
| | Mitochondrial Diseases | 1 | 2015 | 68 | 0.150 |
Why?
| | Guanylate Cyclase | 1 | 2014 | 40 | 0.140 |
Why?
| | Microvessels | 1 | 2015 | 80 | 0.140 |
Why?
| | Animals | 13 | 2019 | 35394 | 0.140 |
Why?
| | Intubation, Gastrointestinal | 1 | 2014 | 55 | 0.140 |
Why?
| | Cyclic GMP | 1 | 2014 | 132 | 0.140 |
Why?
| | Injections, Intravenous | 1 | 2014 | 255 | 0.140 |
Why?
| | Rats | 8 | 2015 | 6387 | 0.140 |
Why?
| | Endothelial Cells | 1 | 2019 | 650 | 0.130 |
Why?
| | Arthritis, Rheumatoid | 1 | 2021 | 903 | 0.130 |
Why?
| | Organ Culture Techniques | 1 | 2013 | 173 | 0.130 |
Why?
| | Coal Mining | 1 | 2013 | 2 | 0.130 |
Why?
| | Neutrophils | 1 | 2019 | 1324 | 0.130 |
Why?
| | Air Pollution | 1 | 2015 | 178 | 0.130 |
Why?
| | Trachea | 1 | 2015 | 229 | 0.130 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 210 | 0.120 |
Why?
| | Busulfan | 1 | 2012 | 21 | 0.120 |
Why?
| | Pneumonia | 2 | 2015 | 558 | 0.120 |
Why?
| | Vasoconstriction | 1 | 2013 | 211 | 0.120 |
Why?
| | Mitochondria | 2 | 2015 | 810 | 0.120 |
Why?
| | Nanotubes, Carbon | 1 | 2012 | 46 | 0.120 |
Why?
| | Alanine | 1 | 2012 | 104 | 0.120 |
Why?
| | Administration, Oral | 1 | 2014 | 798 | 0.120 |
Why?
| | Macrophages | 1 | 2019 | 1343 | 0.120 |
Why?
| | Xenobiotics | 1 | 2012 | 26 | 0.120 |
Why?
| | Nanostructures | 1 | 2013 | 113 | 0.120 |
Why?
| | Hydroxyl Radical | 1 | 2012 | 89 | 0.120 |
Why?
| | Heart Diseases | 1 | 2015 | 368 | 0.120 |
Why?
| | Maternal Exposure | 1 | 2013 | 134 | 0.110 |
Why?
| | Endothelium, Vascular | 3 | 2013 | 973 | 0.110 |
Why?
| | Glutathione | 1 | 2012 | 365 | 0.110 |
Why?
| | Vascular Diseases | 1 | 2013 | 227 | 0.100 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2015 | 467 | 0.100 |
Why?
| | Air Pollutants | 1 | 2013 | 276 | 0.100 |
Why?
| | Gene Expression | 1 | 2015 | 1588 | 0.100 |
Why?
| | Nitric Oxide | 1 | 2014 | 883 | 0.100 |
Why?
| | Fetus | 1 | 2013 | 680 | 0.090 |
Why?
| | Liver | 2 | 2015 | 1867 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2014 | 1032 | 0.090 |
Why?
| | Male | 9 | 2021 | 60993 | 0.090 |
Why?
| | Oxidative Stress | 3 | 2019 | 1244 | 0.080 |
Why?
| | Apoptosis | 3 | 2019 | 2675 | 0.070 |
Why?
| | Interleukin-6 | 2 | 2019 | 716 | 0.070 |
Why?
| | Hydrogen Peroxide | 2 | 2015 | 311 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 1711 | 0.050 |
Why?
| | Cell Degranulation | 1 | 2019 | 38 | 0.050 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2019 | 61 | 0.050 |
Why?
| | RAW 264.7 Cells | 1 | 2019 | 46 | 0.050 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2019 | 132 | 0.050 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2019 | 218 | 0.050 |
Why?
| | Solubility | 1 | 2019 | 275 | 0.050 |
Why?
| | Surface Properties | 1 | 2019 | 431 | 0.040 |
Why?
| | Respiratory Function Tests | 1 | 2019 | 595 | 0.040 |
Why?
| | Phagocytosis | 1 | 2019 | 386 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2019 | 357 | 0.040 |
Why?
| | Mice | 3 | 2019 | 15641 | 0.040 |
Why?
| | In Situ Nick-End Labeling | 1 | 2015 | 138 | 0.040 |
Why?
| | Cell Respiration | 1 | 2015 | 83 | 0.040 |
Why?
| | Injections, Spinal | 1 | 2015 | 150 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 960 | 0.040 |
Why?
| | Tungsten Compounds | 1 | 2015 | 5 | 0.040 |
Why?
| | Cell Survival | 1 | 2019 | 1188 | 0.040 |
Why?
| | Toxicity Tests, Acute | 1 | 2015 | 11 | 0.040 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 91 | 0.040 |
Why?
| | Cobalt | 1 | 2015 | 51 | 0.040 |
Why?
| | Uterine Artery | 1 | 2015 | 68 | 0.040 |
Why?
| | Mechanotransduction, Cellular | 1 | 2015 | 94 | 0.030 |
Why?
| | Caspases | 1 | 2015 | 293 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 387 | 0.030 |
Why?
| | Splanchnic Circulation | 1 | 2013 | 13 | 0.030 |
Why?
| | Appalachian Region | 1 | 2013 | 18 | 0.030 |
Why?
| | Uterine Contraction | 1 | 2013 | 18 | 0.030 |
Why?
| | Environmental Monitoring | 1 | 2015 | 297 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2012 | 56 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 3016 | 0.030 |
Why?
| | Nitroprusside | 1 | 2012 | 97 | 0.030 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 36 | 0.030 |
Why?
| | Phenylephrine | 1 | 2012 | 114 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2015 | 664 | 0.030 |
Why?
| | Pregnancy | 2 | 2015 | 5290 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 835 | 0.030 |
Why?
| | Coronary Circulation | 1 | 2013 | 171 | 0.030 |
Why?
| | DNA Damage | 1 | 2015 | 373 | 0.030 |
Why?
| | Inhalation Exposure | 1 | 2013 | 100 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1640 | 0.030 |
Why?
| | Biocatalysis | 1 | 2012 | 70 | 0.030 |
Why?
| | Echocardiography | 1 | 2015 | 637 | 0.030 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2012 | 97 | 0.030 |
Why?
| | Aerosols | 1 | 2013 | 171 | 0.030 |
Why?
| | Glutathione Transferase | 1 | 2012 | 119 | 0.030 |
Why?
| | Acetylcholine | 1 | 2012 | 209 | 0.030 |
Why?
| | Humans | 4 | 2021 | 113846 | 0.030 |
Why?
| | Metals | 1 | 2013 | 124 | 0.030 |
Why?
| | Arterial Pressure | 1 | 2012 | 110 | 0.030 |
Why?
| | Microscopy | 1 | 2013 | 125 | 0.030 |
Why?
| | Uterus | 1 | 2013 | 201 | 0.030 |
Why?
| | Organ Size | 1 | 2012 | 499 | 0.030 |
Why?
| | Cytokines | 1 | 2019 | 1981 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2015 | 538 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2012 | 348 | 0.030 |
Why?
| | Iron | 1 | 2012 | 240 | 0.030 |
Why?
| | Fetal Development | 1 | 2013 | 231 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2012 | 398 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 655 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1251 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2012 | 1050 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3501 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 483 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1800 | 0.020 |
Why?
| | Heart | 1 | 2012 | 685 | 0.020 |
Why?
| | Antioxidants | 1 | 2012 | 570 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 9050 | 0.020 |
Why?
| | Myocardium | 1 | 2012 | 1095 | 0.020 |
Why?
| | Female | 3 | 2021 | 63035 | 0.020 |
Why?
| | Kidney | 1 | 2012 | 1211 | 0.020 |
Why?
| | Inflammation | 1 | 2015 | 2451 | 0.020 |
Why?
| | Time Factors | 1 | 2012 | 7060 | 0.010 |
Why?
|
|
Minarchick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|